Empowering appropriate antimicrobial use with rapid diagnostics.

Rapid Testing

Research indicates that countries' antibiotic-prescribing rates are linked to resistance rates1,2 and, consequently, that the reduction of unnecessary prescribing, particularly for acute respiratory tract infections (ARTIs), could directly contribute to lower resistance.6 Interventions such as CRP point-of-care testing can help promote a more prudent use of antibiotics.3,4 Use of point-of-care tests for CRP have been shown to significantly reduce antibiotic prescribing for lower respiratory tract infections without compromising either patients' recovery or satisfaction with care.1 It has also been shown that physicians with access to CRP tests significantly reduced antibiotic prescriptions in patients with rhinosinusitis.11

 

Afinion™ CRP and NycoCard™ CRP

The Alere Afinion™ CRP test is an important point-of-care assay to help discriminate serious illness such as pneumonia from often self-limiting illness like acute bronchitis and other RTI.5

Alere Afinion™ CRP is a rapid in vitro diagnostic test for quantitative determination of C-reactive protein (CRP) in human blood; helping reduce diagnostic uncertainty and guiding antibiotic decision making during your patient’s visit. The fully automated Alere Afinion™ CRP test provides, with excellent precision and user friendliness, an answer in 4 minutes.

C-reactive protein (CRP) is one of the cytokine induced acute-phase proteins, the levels of which rise during a response to infectious and non-infectious inflammatory processes.8,9 In healthy persons the serum or plasma CRP levels are below 5 mg/L.9,10 As elevated CRP levels are always associated with pathological changes, the CRP assay provides information for the diagnosis, therapy and monitoring of inflammatory diseases.7,8,9,10

Product not available in US.